DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar KyBubba1 (< 20) Submitted: 1/11/2010 5:50:34 PM : Outperform Start Price: $61.63 DVA Score: +16.75

Increasing customer base, company knows how to manage financials

Featured Broker Partners


Advertisement